These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30530211)

  • 21. Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system.
    Li Y; Zhang W; Zhao J; Li S; Shan L; Zhu J; Li Y; Zhu H; Mao Q; Xia H
    Cytotechnology; 2018 Dec; 70(6):1595-1605. PubMed ID: 30173403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement and use of CRISPR/Cas9 to engineer a sperm-marking strain for the invasive fruit pest Drosophila suzukii.
    Ahmed HMM; Hildebrand L; Wimmer EA
    BMC Biotechnol; 2019 Dec; 19(1):85. PubMed ID: 31805916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient Multiplex Genome Editing Induces Precise, and Self-Ligated Type Mutations in Tomato Plants.
    Hashimoto R; Ueta R; Abe C; Osakabe Y; Osakabe K
    Front Plant Sci; 2018; 9():916. PubMed ID: 30018630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient gene editing in
    Matsu-Ura T; Baek M; Kwon J; Hong C
    Fungal Biol Biotechnol; 2015; 2():4. PubMed ID: 28955455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
    Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
    Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing.
    Degreif D; Kremenovic M; Geiger T; Bertl A
    J Biol Methods; 2018; 5(3):e98. PubMed ID: 31453248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
    Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
    Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing.
    Pazmiño-Ibarra V; Mengual-Martí A; Targovnik AM; Herrero S
    Biotechnol Bioeng; 2019 Nov; 116(11):2823-2833. PubMed ID: 31403180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bidirectional Promoter-Based CRISPR-Cas9 Systems for Plant Genome Editing.
    Ren Q; Zhong Z; Wang Y; You Q; Li Q; Yuan M; He Y; Qi C; Tang X; Zheng X; Zhang T; Qi Y; Zhang Y
    Front Plant Sci; 2019; 10():1173. PubMed ID: 31616455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Highly Efficient Cell Division-Specific CRISPR/Cas9 System Generates Homozygous Mutants for Multiple Genes in
    Feng Z; Zhang Z; Hua K; Gao X; Mao Y; Botella JR; Zhu JK
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of Pol III U6 promoters for gene knockdown and knockout in Plutella xylostella.
    Huang Y; Wang Y; Zeng B; Liu Z; Xu X; Meng Q; Huang Y; Yang G; Vasseur L; Gurr GM; You M
    Insect Biochem Mol Biol; 2017 Oct; 89():71-78. PubMed ID: 28890398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized guide RNA structure for genome editing via Cas9.
    Xu J; Lian W; Jia Y; Li L; Huang Z
    Oncotarget; 2017 Nov; 8(55):94166-94171. PubMed ID: 29212218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA Polymerase II Activity of Type 3 Pol III Promoters.
    Gao Z; Herrera-Carrillo E; Berkhout B
    Mol Ther Nucleic Acids; 2018 Sep; 12():135-145. PubMed ID: 30195753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
    Li L; Hu S; Chen X
    Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.
    Huo W; Zhao G; Yin J; Ouyang X; Wang Y; Yang C; Wang B; Dong P; Wang Z; Watari H; Chaum E; Pfeffer LM; Yue J
    J Cancer; 2017; 8(1):57-64. PubMed ID: 28123598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.